KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Change in Inventory: 2017-2024

Historic Change in Inventory for Aquestive Therapeutics (AQST) over the last 8 years, with Dec 2024 value amounting to -$725,000.

  • Aquestive Therapeutics' Change in Inventory fell 538.18% to -$241,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $863,000, marking a year-over-year increase of 1587.93%. This contributed to the annual value of -$725,000 for FY2024, which is 173.31% down from last year.
  • Latest data reveals that Aquestive Therapeutics reported Change in Inventory of -$725,000 as of FY2024, which was down 173.31% from $989,000 recorded in FY2023.
  • In the past 5 years, Aquestive Therapeutics' Change in Inventory registered a high of $1.7 million during FY2022, and its lowest value of -$725,000 during FY2024.
  • In the last 3 years, Aquestive Therapeutics' Change in Inventory had a median value of $989,000 in 2023 and averaged $669,000.
  • As far as peak fluctuations go, Aquestive Therapeutics' Change in Inventory surged by 496.23% in 2021, and later slumped by 173.31% in 2024.
  • Yearly analysis of 5 years shows Aquestive Therapeutics' Change in Inventory stood at -$398,000 in 2020, then surged by 496.23% to $1.6 million in 2021, then grew by 10.53% to $1.7 million in 2022, then slumped by 43.26% to $989,000 in 2023, then tumbled by 173.31% to -$725,000 in 2024.